I mproved methods of diagnosis and treatment of cardiovascular atherosclerotic disease would reduce stroke-related mortality, improve the quality of life of stroke survivors, and result in a reduction of stroke related health care costs.
MRI, if properly utilized, can be a promising tool for in vivo studies of the patho-physiology of human atherosclerosis progression and regression. In vivo MRI studies can improve scientific understanding of cardiovascular disease mechanisms and its associated risk factors, which would allow for improved identification of high-risk stroke and heart disease individuals. This would also allow for more selective and appropriate clinical intervention.
VIL is divided into the following interrelated Research Groups: